Pancreatic Cancer Research

ResearcherWestern University of Health SciencesNo recent work listed

Jeffrey Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6918-2821; OpenAlex author ID A5100641853. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: none · 2015: 2 papers · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 2 papers · 2020: 1 paper

Papers 10

  1. Efficacy and Pharmacokinetic Considerations of Loratadine Nanoformulations and its Combinations for Pancreatic Cancer Chemoprevention. Co-author DOI 10.1007/s11095-019-2737-x↗
  2. Loratadine self-microemulsifying drug delivery systems (SMEDDS) in combination with sulforaphane for the synergistic chemoprevention of pancreatic cancer. Co-author DOI 10.1007/s13346-019-00619-0↗
  3. Pancreatic Cancer: Recent Advances in Nanoformulation-Based Therapies. Co-author DOI 10.1615/critrevtherdrugcarriersyst.2018025459↗
  4. Novel nano-drug combination therapeutic regimen demonstrates significant efficacy in the transgenic mouse model of pancreatic ductal adenocarcinoma. Co-author PMID 30416852↗
  5. Triptolide and celastrol loaded silk fibroin nanoparticles show synergistic effect against human pancreatic cancer cells. Last author DOI 10.1039/c7nr03016a↗
  6. Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanopartic… Co-author DOI 10.1186/s13578-015-0041-y↗
  7. Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention. Co-author DOI 10.3892/ijo.2015.2879↗
  8. A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions. Co-author DOI 10.1158/1940-6207.capr-13-0172↗
  9. The molecular mechanism of action of aspirin, curcumin and sulforaphane combinations in the chemoprevention of pancreatic cancer. Co-author DOI 10.3892/or.2013.2276↗
  10. Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen. Co-author DOI 10.3892/ijo.2012.1636↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sunil V. Prabhu · 10 shared papers, 2012–2020 · strength 0.85
  2. Arvind D. Thakkar · 8 shared papers, 2012–2019 · strength 0.57
  3. Preshita Prafulla Desai · 4 shared papers, 2018–2020 · strength 0.49
  4. B. Karthik Grandhi · 3 shared papers, 2012–2013 · strength 0.14
  5. Dhruvitkumar S. Sutaria · 2 shared papers, 2012–2013 · strength 0.09
  6. Baoyue Ding · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.